STING1 and neoplasm: Intratumoral injection of heat-inactivated MVA induces innate immunity via the STING pathway, which enhances tumor antigen presentation, promotes dendritic cell maturation, stimulates naïve T cell priming, increases tumor-specific T cell expansion and migration, and boosts cytotoxic T lymphocyte (CTL)-mediated killing of cancer cells [104–106].